• About us
• Contact

Advertisement

Person › Details

Hidenobu Ishizaki (Noile-Immune Biotech Inc. (JP))

Ishizaki, Hidenobu (Noile-Immune 201908 CEO)

 

	Organisation	Noile-Immune Biotech Inc. (JP)
	Product	CAR T-cell technology (Chimeric Antigen Receptor T-Cell technology)
	Product 2	oncology

Record changed: 2019-08-27

Advertisement

More documents for Hidenobu Ishizaki

• [1] Adaptimmune Therapeutics plc. (8/27/19). "Press Release: Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products Expressing IL-7 and CCL19 as a Next-generation Treatment for Cancer Patients". Philadeliphia, PA & Oxfordshire....
• [2] Vaccitech Ltd.. (8/27/19). "Press Release: Vaccitech Appoints Bill Enright as New Chief Executive Officer". Philadeliphia, PA & Oxfordshire....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.